Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China flag China · Delayed Price · Currency is CNY
12.13
+0.18 (1.51%)
Feb 4, 2026, 3:04 PM CST

SHE:002900 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
641.63794.07991.161,203529.83661.45
Trading Asset Securities
93.3148.0857.7591.25581.68360.79
Cash & Short-Term Investments
734.94842.151,0491,2941,1121,022
Cash Growth
-12.57%-19.71%-18.93%16.41%8.73%-14.33%
Accounts Receivable
94.41221.1999.46124.6132.98157.85
Other Receivables
6.2613.361.730.990.642.85
Receivables
100.67234.55101.19125.59133.62160.7
Inventory
256.37307.67208.79161.16156.55186.51
Other Current Assets
95.8587.5977.5443.0125.5170.71
Total Current Assets
1,1881,4721,4361,6241,4271,440
Property, Plant & Equipment
1,4681,4021,082882.45925.35867.29
Long-Term Investments
708.36711.73708.99646.87604.514.91
Goodwill
1.341.341.340.59.449.44
Other Intangible Assets
123.03112.95113.3761.162.566.42
Long-Term Deferred Tax Assets
35.8225.2223.0824.6825.8423.89
Long-Term Deferred Charges
75.7266.3857.9638.410.6956.85
Other Long-Term Assets
9.348.8820.22--3.8
Total Assets
3,6093,8003,4433,2783,0662,483
Accounts Payable
303.03323.48182.13120.84105.1690.01
Accrued Expenses
9.2839.6878.7999.3107.57129.46
Short-Term Debt
782.82575.96275.27220.22270.28269.78
Current Portion of Long-Term Debt
37.58217.45201.5410.170.06-
Current Portion of Leases
-3.353.423.44.46-
Current Income Taxes Payable
2.360.320.040.010.020.27
Current Unearned Revenue
15.7417.7743.2554.7921.0619.42
Other Current Liabilities
69.2179.7260.618927.9979.89
Total Current Liabilities
1,2201,258845.03597.73536.61588.84
Long-Term Debt
217.35134.19229.83417.78204.84-
Long-Term Leases
3.164.688.335.148.03-
Long-Term Unearned Revenue
131.79103.9179.0383.8688.9688.71
Long-Term Deferred Tax Liabilities
131.96135.8132.54120.95110.6113.63
Total Liabilities
1,7041,6361,2951,225949.04691.18
Common Stock
316.36316.36316.39316.6316.6316.6
Additional Paid-In Capital
1,0931,0901,0821,0431,0731,073
Retained Earnings
494.52766.64771.23729.21797.94471.77
Treasury Stock
-0.02-13.14-29.54-47.79-85.77-85.77
Total Common Equity
1,9042,1602,1402,0412,1011,775
Minority Interest
1.44.037.7311.3215.0216.3
Shareholders' Equity
1,9052,1642,1482,0522,1161,792
Total Liabilities & Equity
3,6093,8003,4433,2783,0662,483
Total Debt
1,041935.63718.38656.73487.67269.78
Net Cash (Debt)
-305.98-93.47330.54637.17623.84752.46
Net Cash Growth
---48.12%2.14%-17.09%-25.74%
Net Cash Per Share
-0.98-0.301.082.112.012.31
Filing Date Shares Outstanding
312.1298.74278.39309.78309.78309.78
Total Common Shares Outstanding
312.1298.74278.39309.78309.78309.78
Working Capital
-32.18214.23591.41,026890.58851.32
Book Value Per Share
6.107.237.696.596.785.73
Tangible Book Value
1,7792,0462,0261,9792,0301,699
Tangible Book Value Per Share
5.706.857.286.396.555.49
Buildings
-913.01644.88635.65640.66603.42
Machinery
-1,056799.09737.21716.18579.06
Construction In Progress
-162.84269.2658.3445.31153.26
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.